Joint Formulary & PAD

Irbesartan / Hydrochlorothiazide - Hypertension

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green (see narrative)
Formulations :
  • Not Specified
Associated Icons :
Restrictions / Comments :
Important
MHRA alert: Hydrochlorothiazide risk of non-melanoma skin cancer

PAD Profile

ChemicalSubstance :
Irbesartan / Hydrochlorothiazide
Indication :
Hypertension
Group Name :
Keywords :
Brand Names Include :
Co-Aprovel
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1